Dr Linette Mejias Badillo, MD | |
205 E Palmer Rd, Bellefontaine, OH 43311-2281 | |
(937) 599-1124 | |
Not Available |
Full Name | Dr Linette Mejias Badillo |
---|---|
Gender | Female |
Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
Location | 205 E Palmer Rd, Bellefontaine, Ohio |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134563968 | NPI | - | NPPES |
0260744 | Medicaid | OH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 35.128448 (Ohio) | Primary |
Entity Name | Laboratorio De Patologia Dr Noy |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1225016140 PECOS PAC ID: 8325062714 Enrollment ID: O20060125000021 |
News Archive
The program, set up by Advocate, covers 380,000 enrollees, the Chicago Sun-Times reports. Meanwhile, other outlets look at health law implementation efforts in Massachusetts and California.
BioAlliance Pharma SA (Euronext Paris – BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced the approval from the French Drug Agency (AFSSaPS) to enter first Phase I clinical trial for Fentanyl Lauriad®.
Scientists at The Scripps Research Institute (TSRI) have published one of the first laboratory studies of MDPV, an emerging recreational drug that has been sold as "bath salts." The TSRI researchers confirmed the drug's powerful stimulant effects in rats and found evidence that it could be more addictive than methamphetamine, one of the most addictive substances to date.
Recently, a team of researchers from Arizona State University has discovered micro and nanoplastics in human tissues and organs. The study was presented at the American Chemical Society's virtual expo.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Linette Mejias Badillo, MD 205 E Palmer Rd, Bellefontaine, OH 43311-2281 Ph: (937) 599-1124 | Dr Linette Mejias Badillo, MD 205 E Palmer Rd, Bellefontaine, OH 43311-2281 Ph: (937) 599-1124 |
News Archive
The program, set up by Advocate, covers 380,000 enrollees, the Chicago Sun-Times reports. Meanwhile, other outlets look at health law implementation efforts in Massachusetts and California.
BioAlliance Pharma SA (Euronext Paris – BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced the approval from the French Drug Agency (AFSSaPS) to enter first Phase I clinical trial for Fentanyl Lauriad®.
Scientists at The Scripps Research Institute (TSRI) have published one of the first laboratory studies of MDPV, an emerging recreational drug that has been sold as "bath salts." The TSRI researchers confirmed the drug's powerful stimulant effects in rats and found evidence that it could be more addictive than methamphetamine, one of the most addictive substances to date.
Recently, a team of researchers from Arizona State University has discovered micro and nanoplastics in human tissues and organs. The study was presented at the American Chemical Society's virtual expo.
› Verified 1 days ago